Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CGTX market cap is 16.53M. The company's latest EPS is USD -0.6207 and P/E is -0.64.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.82M | -14.75M | -15.19M | -14.1M | -14.68M |
| Net Income | -4.73M | -6.75M | -8.14M | -9.15M | -7.04M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -17.41M | -28.6M | -43.55M | -50.72M |
| Net Income | -12.07M | -16.25M | -21.4M | -25.79M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Total Assets | 43.96M | 38.77M | 35.16M | 38.85M | 34.37M |
| Total Liabilities | 9.57M | 9.85M | 10.69M | 9.99M | 11.36M |
| Total Equity | 34.39M | 28.93M | 24.47M | 28.86M | 23.01M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 7.12M | 59.14M | 50.43M | 35.16M |
| Total Liabilities | 19.93M | 7.86M | 10.18M | 10.69M |
| Total Equity | -68.18M | 51.27M | 40.25M | 24.47M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | ||
| Operating | -6.4M | -10.56M | -16.02M | -7.24M | -13.24M |
| Investing | -59k | -117k | -147k | N/A | -3k |
| Financing | 2.09M | 2.08M | 4.52M | 11.99M | 11.86M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.43M | -3.63M | -18.53M | -16.02M |
| Investing | -10k | -27k | -171k | -147k |
| Financing | 5.77M | 53.2M | 5.55M | 4.52M |
| Market Cap | 16.53M |
| Price to Earnings Ratio | -0.64 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.56 |
| Price to Book Ratio | 0.68 |
| Dividend Yield | - |
| Shares Outstanding | 41.55M |
| Average Volume (1 week) | 13.95M |
| Average Volume (1 Month) | 3.24M |
| 52 Week Change | -62.10% |
| 52 Week High | 3.44 |
| 52 Week Low | 0.34 |
| Spread (Intraday) | 0.02 (3.93%) |
| Company Name | Cognition Therapeutics Inc |
| Address |
2140 s dupont hwy camden, delaware 19934 |
| Website | https://www.cogrx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
